Chugai Pharmaceutical Co., Ltd

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange 01:00:00 2024-03-04 am EST 5-day change 1st Jan Change
6,272 JPY +2.67% Intraday chart for Chugai Pharmaceutical Co., Ltd +11.05% +17.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jefferies Adjusts Chugai’s Price Target to 7,000 Yen From 6,200 Yen, Keeps at Buy MT
Interest Rates, Central Bank Outlooks Churn Asian Stock Markets MT
Nikkei extends record rally on pharma boost RE
Nikkei hits record high as index heavyweights advance RE
US Tech Outlook Boost Asian Stock Markets MT
Global markets live: Sanofi, ABB, Qualcomm, Roche, Shell... Our Logo
Chugai Pharmaceutical’s Profit Down 13% in 2023 MT
Chugai Pharmaceutical Co., Ltd. Provides Consolidated Non-Audited Earnings Guidance for the Financial Year 2024 CI
From scandal to delisting: Toshiba's long-running crisis RE
Jefferies Adjusts Chugai Pharmaceutical’s Price Target to 6,200 Yen From 5,400 Yen, Keeps at Buy MT
Transcript : Chugai Pharmaceutical Co., Ltd. - Pre Recorded Special Call
Jefferies: Investor Interest Shifts from Daiichi Sankyo to Chugai and Otsuka Holdings MT
Chugai Pharmaceutical’s Attributable Profit down 13.9% in Fiscal due to One-Off Lump-Sum Settlement;Shares Shed over 2.6% MT
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement MT
Chugai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Nine Months and Financial Year Ending December 31, 2023 CI
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending December 31, 2023 CI
Roche, Biogen Settle US Patent Infringement Case Over Actemra Biosimilar MT
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug RE
Jefferies Adjusts Chugai Pharmaceutical's Price Target to 5,400 Yen From 5,200 Yen, Keeps at Buy MT
Japan's Nikkei posts biggest one-day drop in a month, rate jitters weigh RE
Japan's Nikkei hits one-month low on Fed's higher-for-longer rate woes RE
China Profits, Central Bank Outlooks Lift Asian Stock Markets MT
Japan's Nikkei recoups losses, ends higher on dividend hunting RE
Jefferies Adjusts Chugai Pharmaceutical's Price Target to 5,200 Yen From 4,600 Yen, Keeps at Buy MT
Nikkei slides for second day as chip rout accelerates RE
Chart Chugai Pharmaceutical Co., Ltd
More charts
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%). Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6,272 JPY
Average target price
5,923 JPY
Spread / Average Target
-5.57%
Consensus
  1. Stock
  2. Equities
  3. Stock Chugai Pharmaceutical Co., Ltd - Japan Exchange
  4. News Chugai Pharmaceutical Co., Ltd
  5. Jefferies: Investor Interest Shifts from Daiichi Sankyo to Chugai and Otsuka Holdings
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW